INS and glucose measurement: The combined activation of GIPR and GLP-1R by tirzepatide not only improved both glucose-dependent insulin secretion and glucose tolerance in mice15, but also showed significantly better efficacy than semaglutide and dulaglutide with regard to glucose control and weight loss16,17.